Allen Klee Analyst PerformanceManaging Director, Senior Research Analyst at Maxim GroupAllen Klee is a stock analyst at Maxim Group across a range of sectors, covering 42 publicly traded companies. Over the past year, Allen Klee has issued 14 stock ratings, including strong buy, buy, and hold recommendations. While full access to Allen Klee's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Allen Klee's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings107 Last 7 YearsBuy Recommendations88.57% 93 Buy RatingsCompanies Covered42 Unique Companies Ratings Distribution105RatingsDistribution of strong buy, buy, hold, and sell ratings by Allen Klee.RatingPercentageCount Strong Buy1.9%2 ratings Buy86.7%91 ratings Hold11.4%12 ratings Sell0.0%0 ratingsOut of 105 total stock ratings issued by Allen Klee at Maxim Group, the majority (86.7%) have been Buy recommendations, followed by 11.4% Hold and 1.9% Strong Buy.Best & Worst CallsBest Call0000.0%BOXLMay 2020Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%TEUMMar 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ81.0% of companies on NASDAQ34 companiesNYSEAMERICAN11.9% of companies on NYSEAMERICAN5 companiesNYSE4.8% of companies on NYSE2 companiesOTCMKTS2.4% of companies on OTCMKTS1 companyAllen Klee, an analyst at Maxim Group, currently covers 42 companies listed on NASDAQ, NYSEAMERICAN, NYSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageComputer and Technology15 companies35.7%Business Services11 companies26.2%Consumer Discretionary3 companies7.1%Industrials3 companies7.1%Medical3 companies7.1%Finance2 companies4.8%Services1 company2.4%Multi-Sector Conglomerates1 company2.4%Retail/Wholesale1 company2.4%Transportation1 company2.4%Aerospace1 company2.4%Allen Klee of Maxim Group specializes in stock coverage within the Computer and Technology sector, with additional focus on Business Services and Consumer Discretionary companies.Coverage IndustriesIndustryPercentageTECHNOLOGY SERVICES9 companies21.4%INTERNET SOFTWARE4 companies9.5%PROTECTION - SFTY2 companies4.8%COMP - SERVICES2 companies4.8%CONS SERVICES - MISC1 company2.4%SERVICES – COMPUTER PROCESSING, DATA PREPARATION AND PROCESSING1 company2.4%MEDICAL SERVICES1 company2.4%IT SERVICES1 company2.4%DIVERSIFIED OPS1 company2.4%INSURANCE AGENTS, BROKERS & SERVICE1 company2.4%INS - BROKERS1 company2.4%COMP - OPTICL REC1 company2.4%LEISURE&REC SVS1 company2.4%INTERNET CONTENT1 company2.4%MEDICAL CARE FACILITIES1 company2.4%BUSINESS SERVICES, NOT ELSEWHERE CLASSIFIED1 company2.4%CUSTOM COMPUTER PROGRAMMING SERVICES1 company2.4%PRINTING - COMMRL1 company2.4%DATA PROCESSING & PREPARATION1 company2.4%SURGICAL & MEDICAL INSTRUMENTS1 company2.4%COMP - INTEGT SYS1 company2.4%WIRELESS NATIONAL1 company2.4%INTERNET COMMERCE1 company2.4%AUDIO/VIDEO PRD1 company2.4%AUTOMOTIVE RENTAL & LEASING, WITHOUT DRIVERS1 company2.4%OFFICE AUTO&EQP1 company2.4%ELEC - MILITARY1 company2.4%COMPUTER INTEGRATED SYSTEMS DESIGN1 company2.4%INTERNET SERVICES1 company2.4% About Allen KleeAllen Klee is Managing Director, Senior Equity Research Analyst at Maxim Group LLC covering tech, telecom, media, and healthcare technology. Prior to joining Maxim, Mr. Klee was a Managing Director, Equity Analyst covering TMT at National Securities Corporation. Prior sell-side experience includes working at Maxim Group as an SVP of Equity Research and Sidoti & Company, LLC as a Senior Equity Analyst also covering TMT. Other experience includes buy-side roles as a Prop Trader at Xanthus Capital, Equity Analyst at both Casey Capital and Sigma Capital, and as a Portfolio Manager for small and midcap mutual funds at both First Investors Corporation and Guardian Life Insurance. Prior to that, Mr. Klee was a Senior Credit Analyst at both Guardian Life Insurance and at Moody’s Investor Service. Mr. Klee earned his MBA in Finance from the NYU Stern School of Business and has a B.S. from Rutgers University with a double major in BioMathematics and Economics. He also holds the CFA designation.Follow on LinkedIn Allen Klee's Ratings History at Maxim Group Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsEEXEmerald5/11/2026Downgrade$5.00Hold$0.0000.00% ROICASTFreeCast (Direct Listing)4/24/2026Initiated Coverage$2.16$6.00Buy$0.0000.00% ROIORKTOrangekloud Technology4/20/2026Downgrade$1.08Hold$0.0000.00% ROIDEFTDeFi Technologies4/13/2026Lower Price Target$0.76$1.50Buy$0.0000.00% ROIITRNIturan Location and Control3/12/2026Initiated Coverage$49.97$70.00Buy$0.0000.00% ROICCELCryo-Cell International10/20/2025Downgrade$4.55Hold$0.0000.00% ROIIDAIT Stamp9/19/2025Boost Price Target$2.89$12.00Buy$0.0000.00% ROIJTAIJet.AI8/20/2025Lower Price Target$608.00$2,200.00Buy$0.0000.00% ROIAIREreAlpha Tech7/28/2025Reiterated Rating$0.42Hold$0.0000.00% ROIHITHealth In Tech6/26/2025Upgrade$0.76$2.50Strong-Buy$0.0000.00% ROIOMHOhmyhome6/16/2025Downgrade$1.42Hold$0.0000.00% ROIARBBARB IOT Group6/9/2025Upgrade$5.73$20.00Strong-Buy$0.0000.00% ROIDEFTDeFi Technologies5/27/2025Boost Price Target$3.72$7.00Buy$0.0000.00% ROIAIREreAlpha Tech5/21/2025Lower Price Target$13.30$31.25Buy$0.0000.00% ROIOXBROxbridge Re4/30/2025Initiated Coverage$1.33$5.00Buy$0.0000.00% ROICTMCastellum4/24/2025Set Price Target$0.99$3.00Buy$0.0000.00% ROICCELCryo-Cell International3/4/2025Lower Price Target$6.60$8.50Buy$0.0000.00% ROIVSEEVSee Health2/24/2025Initiated Coverage$1.82$5.00Buy$0.0000.00% ROIINODInnodata2/21/2025Boost Price Target$62.45$75.00Buy$00.0000.00% ROIMITKMitek Systems2/11/2025Boost Price Target$9.91$14.00Buy$00.0000.00% ROIGIFTGiftify2/5/2025Initiated Coverage$1.11$4.00Buy$0.0000.00% ROIORKTOrangekloud Technology1/30/2025Initiated Coverage$5.48$20.00Buy$0.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageRoyal Bank Of CanadaJPMorgan Chase & Co.Berenberg BankWall Street ZenUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyJefferies Financial GroupThe Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.